MS-275 in Treating Patients With Hematologic Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of MS-275 in treating patients who have hematologic cancer.
Epistemonikos ID: 8e80aaad0f8b4f336d7f58f9833b2a8d49142999
First added on: May 03, 2024